A consortium of investors to acquire a majority stake in Unither Pharmaceuticals from Ardian.

A consortium of investors comprised of GIC, IK Partners, Keensight and Parquest and led by Eric Goupil, CEO of Unither agreed to acquire a majority stake in Unither Pharmaceuticals, a contract development and manufacturing organization of pharmaceutical products, from Ardian, a private investment house. Financial terms were not disclosed. "With Ardian’s support, we have been able to strengthen our business in the US, expand into China and continue investing significantly to cope with our customers’ strong demand and fuel our future organic growth. In collaboration with our new partners, GIC and IK and with the support of our historic partners Keensight and Parquest, we are seeking to build on this strong foundation, to continue satisfying our customers and leverage our global footprint," Eric Goupil, Unither CEO.